Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,294 | -5,938 | -4,084 | -1,969 | -8,589 |
| Depreciation Amortization | 759 | 568 | 379 | 189 | 748 |
| Accounts payable and accrued liabilities | 706 | 164 | 380 | 218 | 118 |
| Other Working Capital | 997 | 361 | 695 | 536 | 1,799 |
| Other Operating Activity | -483 | 10 | -261 | -147 | 254 |
| Operating Cash Flow | $-6,316 | $-4,834 | $-2,891 | $-1,172 | $-5,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -157 | -58 | -14 | -8 | -152 |
| Investing Cash Flow | $-157 | $-58 | $-14 | $-8 | $-152 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,120 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -95 |
| Financing Cash Flow | $3,120 | $N/A | $N/A | $N/A | $-95 |
| Beginning Cash Position | 8,150 | 8,150 | 8,150 | 8,150 | 14,066 |
| End Cash Position | 4,798 | 3,257 | 5,245 | 6,970 | 8,150 |
| Net Cash Flow | $-3,352 | $-4,893 | $-2,904 | $-1,180 | $-5,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,316 | -4,834 | -2,891 | -1,172 | -5,670 |
| Capital Expenditure | -157 | -58 | -14 | -8 | -152 |
| Free Cash Flow | -6,472 | -4,893 | -2,905 | -1,180 | -5,822 |